Ann Lab Med.  2019 Nov;39(6):584-586. 10.3343/alm.2019.39.6.584.

Improvement in External Quality Assessment Results for Qualitative Fecal Immunochemical Tests in Korea After Feedback to Manufacturers

• Lee W
• Ryoo N
• Suh HS
• Jeon CH
• Urinalysis and Routine Microscopy Subcommittee
• Korean Association of External Quality Assessment Service

• KMID: 2450956
• DOI: http://doi.org/10.3343/alm.2019.39.6.584

Abstract

No abstract available.

MeSH Terms

Korea*

Reference

1. Inadomi JM. Screening for colorectal neoplasia. N Engl J Med. 2017; 376:149–156. PMID: 28076720.

2. Miller WG, Jones GR, Horowitz GL, Weykamp C. Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem. 2011; 57:1670–1680. PMID: 21965556.

3. Jeon CH, Lee AJ, Kim KD. The Urinalysis and Routine Microscopy Subcommitte, Korean Association of External Quality Assessment Service. Annual report on the external quality assessment scheme for urinalysis and faecal occult blood testing in Korea (2015). J Lab Med Qual Assur. 2016; 38:120–128.

4. Jeon CH, Lee AJ, Kim SG, Suh HS, Bae YC. Annual report on the external quality assessment scheme for urinalysis and faecal occult blood testing in Korea (2016). J Lab Med Qual Assur. 2017; 39:117–123.

5. Fraser CG, Allison JE, Young GP, Halloran SP, Seaman H. A standard for faecal immunochemical tests for haemoglobin evaluation reporting (FITTER). Ann Clin Biochem. 2014; 51:301–302. PMID: 24345727.

6. Åsberg A, Johnsen H, Mikkelsen G, Hov GG. Using probit regression to disclose the analytical performance of qualitative and semi-quantitative tests. Scand J Clin Lab Invest. 2016; 76:515–519. PMID: 27385434.

7. CLSI. Using proficiency testing and alternative assessment to improve medical laboratory quality. 3rd ed. CLSI QMS24. Wayne, PA: Clinical and Laboratory Standards Institute;2016.

8. United States Food and Drug Administration. Guidance for industry and FDA staff–review criteria for assessment of qualitative fecal occult blood in vitro diagnostic devices. Updated on Aug 2007. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfggp/Results.CFM?Doc_Type=1&Doc_IsCur=1&Doc_OFFICE=OIVD&lookandfeel=1&SORT_ORDER=origin,documentdate%20desc.

9. Segnan N, Patnick J, editors. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st ed. Luxembourg: Publications Office of the European Union;2010. p. 103–144.

10. Korean Ministry of Food and Drug Safety. Guideline to establish performance evaluation for fecal occult blood tests. Updated on Feb 2018. http://www.nifds.go.kr/brd/m_15/view.do?seq=11937&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=14.